Samumed completes phase I chronic tendinopathy study

Samumed, a leader in musculoskeletal conditions, announced the successful completion of a phase Iclinical trial in healthy subjects for its potential treatment of chronic tendinopathy, a degenerative and fibrotic condition caused by injuries or overuse and that has no FDA-approved drug treatments today. The study results supported the continuation of the program into future […]

More From BioPortfolio on "Samumed completes phase I chronic tendinopathy study"

Relevant Topics

Clincial TrialsIn a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug ApprovalsIn order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...